» Articles » PMID: 34673962

Racial and Ethnic Disparities in Rates of COVID-19-Associated Hospitalization, Intensive Care Unit Admission, and In-Hospital Death in the United States From March 2020 to February 2021

Abstract

Importance: Racial and ethnic minority groups are disproportionately affected by COVID-19.

Objectives: To evaluate whether rates of severe COVID-19, defined as hospitalization, intensive care unit (ICU) admission, or in-hospital death, are higher among racial and ethnic minority groups compared with non-Hispanic White persons.

Design, Setting, And Participants: This cross-sectional study included 99 counties within 14 US states participating in the COVID-19-Associated Hospitalization Surveillance Network. Participants were persons of all ages hospitalized with COVID-19 from March 1, 2020, to February 28, 2021.

Exposures: Laboratory-confirmed COVID-19-associated hospitalization, defined as a positive SARS-CoV-2 test within 14 days prior to or during hospitalization.

Main Outcomes And Measures: Cumulative age-adjusted rates (per 100 000 population) of hospitalization, ICU admission, and death by race and ethnicity. Rate ratios (RR) were calculated for each racial and ethnic group compared with White persons.

Results: Among 153 692 patients with COVID-19-associated hospitalizations, 143 342 (93.3%) with information on race and ethnicity were included in the analysis. Of these, 105 421 (73.5%) were 50 years or older, 72 159 (50.3%) were male, 28 762 (20.1%) were Hispanic or Latino, 2056 (1.4%) were non-Hispanic American Indian or Alaska Native, 7737 (5.4%) were non-Hispanic Asian or Pacific Islander, 40 806 (28.5%) were non-Hispanic Black, and 63 981 (44.6%) were White. Compared with White persons, American Indian or Alaska Native, Latino, Black, and Asian or Pacific Islander persons were more likely to have higher cumulative age-adjusted rates of hospitalization, ICU admission, and death as follows: American Indian or Alaska Native (hospitalization: RR, 3.70; 95% CI, 3.54-3.87; ICU admission: RR, 6.49; 95% CI, 6.01-7.01; death: RR, 7.19; 95% CI, 6.47-7.99); Latino (hospitalization: RR, 3.06; 95% CI, 3.01-3.10; ICU admission: RR, 4.20; 95% CI, 4.08-4.33; death: RR, 3.85; 95% CI, 3.68-4.01); Black (hospitalization: RR, 2.85; 95% CI, 2.81-2.89; ICU admission: RR, 3.17; 95% CI, 3.09-3.26; death: RR, 2.58; 95% CI, 2.48-2.69); and Asian or Pacific Islander (hospitalization: RR, 1.03; 95% CI, 1.01-1.06; ICU admission: RR, 1.91; 95% CI, 1.83-1.98; death: RR, 1.64; 95% CI, 1.55-1.74).

Conclusions And Relevance: In this cross-sectional analysis, American Indian or Alaska Native, Latino, Black, and Asian or Pacific Islander persons were more likely than White persons to have a COVID-19-associated hospitalization, ICU admission, or in-hospital death during the first year of the US COVID-19 pandemic. Equitable access to COVID-19 preventive measures, including vaccination, is needed to minimize the gap in racial and ethnic disparities of severe COVID-19.

Citing Articles

Differences in COVID-19-Related Hospitalization, Treatment, Complications, and Death by Race and Ethnicity and Area-Level Measures Among Individuals with Cancer in the ASCO Registry.

Ashrafi A, Lin Y, Fong A, Islam J, Anderson T, Ganesan S Cancers (Basel). 2025; 17(5).

PMID: 40075704 PMC: 11898501. DOI: 10.3390/cancers17050857.


Prioritising community-defined interventions to address the health and well-being impact of the COVID-19 pandemic on racially minoritised communities in East London: results from an adapted James Lind Alliance priority setting partnership.

Apea V, Whelan I, Kinsella S, Orkin C BMJ Open. 2025; 15(3):e086922.

PMID: 40074269 PMC: 11904342. DOI: 10.1136/bmjopen-2024-086922.


Role of Gut Microbiota in Long COVID: Impact on Immune Function and Organ System Health.

Pathak A, Agrawal D Arch Microbiol Immunol. 2025; 9(1):38-53.

PMID: 40051430 PMC: 11883900.


Multi-level determinants of vaccination of the American Indian and Alaska Native population: a comprehensive overview.

Zhao J, Jaggad R, Zhang Y, Campbell J, Ghosh P, Kennedye J Front Public Health. 2025; 13:1490286.

PMID: 40041179 PMC: 11877907. DOI: 10.3389/fpubh.2025.1490286.


Recognising the heterogeneity of Indigenous Peoples during the COVID-19 pandemic: a scoping review across Canada, Australia, New Zealand and the USA.

Lyeo J, Liberda E, Ahmed F, Charania N, Moriarity R, Tsuji L BMJ Public Health. 2025; 2(2):e001341.

PMID: 40018612 PMC: 11816692. DOI: 10.1136/bmjph-2024-001341.


References
1.
Millett G, Jones A, Benkeser D, Baral S, Mercer L, Beyrer C . Assessing differential impacts of COVID-19 on black communities. Ann Epidemiol. 2020; 47:37-44. PMC: 7224670. DOI: 10.1016/j.annepidem.2020.05.003. View

2.
Yehia B, Winegar A, Fogel R, Fakih M, Ottenbacher A, Jesser C . Association of Race With Mortality Among Patients Hospitalized With Coronavirus Disease 2019 (COVID-19) at 92 US Hospitals. JAMA Netw Open. 2020; 3(8):e2018039. PMC: 7435340. DOI: 10.1001/jamanetworkopen.2020.18039. View

3.
Garg S, Kim L, Whitaker M, OHalloran A, Cummings C, Holstein R . Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 - COVID-NET, 14 States, March 1-30, 2020. MMWR Morb Mortal Wkly Rep. 2020; 69(15):458-464. PMC: 7755063. DOI: 10.15585/mmwr.mm6915e3. View

4.
Center K, da Silva J, Hernandez A, Vang K, Martin D, Mazurek J . Multidisciplinary Community-Based Investigation of a COVID-19 Outbreak Among Marshallese and Hispanic/Latino Communities - Benton and Washington Counties, Arkansas, March-June 2020. MMWR Morb Mortal Wkly Rep. 2020; 69(48):1807-1811. PMC: 7714036. DOI: 10.15585/mmwr.mm6948a2. View

5.
Azar K, Shen Z, Romanelli R, Lockhart S, Smits K, Robinson S . Disparities In Outcomes Among COVID-19 Patients In A Large Health Care System In California. Health Aff (Millwood). 2020; 39(7):1253-1262. DOI: 10.1377/hlthaff.2020.00598. View